ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,910Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 1155

$602K Total Retail Price of All Prescriptions

Rank: 18 out of 1155

452 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

22% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,244 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 659 545 1 2
SIMVASTATIN 591 520 2 3
LISINOPRIL 487 428 3 1
OMEPRAZOLE 387 323 4 5
AMLODIPINE BESYLATE 375 341 5 6
HYDROCODONE-ACETAMINOPHEN 324 216 S3 6 4
METFORMIN HCL 275 241 7 7
GABAPENTIN 241 167 8 15
METOPROLOL SUCCINATE 223 210 9 17
WARFARIN SODIUM 211 172 10 11
CRESTOR 188 188 11 34
POTASSIUM CHLORIDE 182 179 12 16
ALLOPURINOL 169 144 13 29
FUROSEMIDE 150 138 14 8
TRAZODONE HCL 140 121 15 22
ATORVASTATIN CALCIUM 139 131 16 12
LOSARTAN POTASSIUM 139 136 16 18
CLOPIDOGREL 138 136 18 70
TRAMADOL HCL 126 108 19 32
METOPROLOL TARTRATE 119 119 20 14
TAMSULOSIN HCL 111 109 21 27
CARVEDILOL 106 106 22 28
GLIMEPIRIDE 105 98 23 43
HYDROCHLOROTHIAZIDE 105 104 23 9
MELOXICAM 101 77 25 52
DONEPEZIL HCL 100 91 26 41
PLAVIX 99 96 27 115
SYNTHROID 96 95 28 91
ZOLPIDEM TARTRATE 90 81 29 21
NEXIUM 86 86 30 98
DILTIAZEM ER 82 82 31 141
FLUTICASONE PROPIONATE 81 76 32 37
PREDNISONE 76 71 33 40
PAROXETINE HCL 71 64 34 48
DOXAZOSIN MESYLATE 68 64 35 56
SPIRONOLACTONE-HCTZ 66 61 36 161
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 54 37 26
LEVOXYL 62 62 38 118
CYMBALTA 58 43 39 46
OXYCODONE HCL 58 48 S2 39 23
ATENOLOL 57 43 41 10
LANTUS SOLOSTAR 56 56 42 96
CYCLOBENZAPRINE HCL 56 24 R 42 38
PRAVASTATIN SODIUM 55 47 44 20
CITALOPRAM HBR 54 29 45 19
FENTANYL 52 49 S2 46 64
DIOVAN 51 51 47 74
SPIRIVA 50 37 48 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.